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Summary 
CHRONIC active hepatitis in drug abusers tends to be a histologically less severe disease than 
in non drug abusers in whom it may be of the lupoid variety. Chronic persistent hepatitis 
tends to persist in drug abusers (this may be due to continued abuse) and regress more 
frequently in non drug abusers. 
Introduction 
 This paper reports the effects of drug abuse on the natural history and progression of 
chronic active and chronic persistent hepatitis. This does not appear to have been previously 
described. 
Patients and Methods 
 Forty-six of 139 first visit patients who attended the Drug Advisory and Treatment 
Centre in the Charitable infirmary with a problem of intravenous drug abuse, between May 
1st 1979 and December 31st 1979, had liver biopsies carried out. Eight of these patients had 
chronic active hepatitis; these and 4 other abusers with chronic active, hepatitis who were 
attending the Department of Gastroenterology, were included in this study. They were 
compared with the 10 non drug abusing patients with chronic active hepatitis who were 
attending the Department of Gastroenterology. All patients with chronic active hepatitis were 
on conventional therapy. 
 Twenty of the 46 patients had chronic persistent hepatitis; 12 of these had more than 
one liver biopsy and are included in this study and compared with the 7 non drug abusing 
patients who were attending the Department of Gastroenterology. 
 Each patient was personally interviewed by one of the authors (Y.A.). In the case of 
drug abusers a detailed history of drug abuse was obtained; the duration of abuse, routes of 
administration and sharing of syringes with others. The alcohol consumption of patients was 
calculated according to levels of alcohol concentration of various drinks (McCance and 
Widdowson, 1967). For the purpose of this study alcohol intake was considered mild if less 
than 80 g pure alcohol/day, moderate if between 80g and 120g pure alcohol/day, heavy if 
greater than 120g alcohol/day. 
 Stigmata of chronic liver disease (finger clubbing, spider naevi, palmar erythema, 
Dupuytren’s contractures, leuconychia, hepatomegaly, splenomegaly, ascites, testicular 
atrophy and gynaecomastia) and the presence or absence of tattoos were sought in all patients 
on physical examination. In the case of drug abusers stigmata of such abuse (needle marks, 
infected skin lesions) were also sought. 
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 The following laboratory tests were performed:– haemoglobin, white cell count, 
erythrocyte sedimentation rate, platelet count, prothrombin time, serum alanine and aspartate 
aminotransferase, gamma glutaryl transferase, lactate dehydrogenase, alkaline phosphatase, 
serum bilirubin, HBsAg, anti nuclear factor, smooth muscle antibody and anti mitochondrial 
antibody. 
 Liver biopsy was carried out following informed consent. Two or more liver biopsies 
were carried out in 10 of the 12 drug abusers with chronic active hepatitis, in all the non drug 
abusing patients with chronic active hepatitis and in all the patients with chronic persistent 
hepatitis. The histological diagnosis was made in accordance with the criteria 
TABLE I 
Age, sex and duration of follow up in each group. 
Patient group Number of 
patients 
Male Female Mean age 
(years) 
Mean duration
of follow up 
(months)
CAH-drug abusers 12 11 1 25.6 17.9 
CAH-non abusers 10 5 5 34.5 39.8 
CPH-drug abusers 12 9 3 24.0 15.3 
CPH-non abusers 7 3 4 29.5 29 
suggested in a review by an International Group (1977). Where patients had more than one 
liver biopsy the time in months from the initial biopsy is stated. 
Results 
 The age, sex, duration of follow-up, alcoholic intake, clinical features, biochemical and  
TABLE II 
Alcoholic intake in each group. 
Patient group Number of 
patients 
Heavy Moderate Mild Nil 
CAH-drug abusers 12 3 3 4 2 
CAH-non abusers 10 – 2 2 6 
CPH-drug abusers 12 4 3 2 3 
CPH-non abusers 7 1 – 2 4 
immunological results are tabulated in Tables I-VII. HBsAg status on each group is tabulated 
in Table VIII. 
 In the drug abusing patients with chronic active hepatitis there was no significant 
history of associated illness. Of the 10 non drug abusing patients with chronic active hepatitis, 
one patient was hypothyroid, another had tryrotoxicosis, one patient had ulcerative colitis for 
which he had a panprotocolectomy 5 years previously, one patient had a duodenal ulcer, and 2 
patients had tuberculosis, one of whom was treated with rifampicin and isoniazid for 2 years, 
one patient had several operations for the reimplantation of an ureter, 3 patients had had blood 
transfusions. There was no associated illness in the group of drug abusing patients with 
chronic persistent hepatitis. One of the non drug abusing patients with chronic persistent 
hepatitis had psoriasis. 
 
 
 
 TABLE III 
CAH and CPH. Stigmata of liver disease in drug abusers and non abusers. 
Patient 
group 
Number 
of 
patients 
Number of 
patients 
with 
stigmata 
Finger 
clubbing 
Dupuytren’s 
contractures 
Palmar 
erythema Hepatomegaly 
Spider 
naevi 
CAH-drug abusers 12 3 – – – 3 – 
CAH-non abusers 10 6 2 1 3 3 1 
CPH-drug abusers 12 2 – – – 1 1 
CPH-non abusers 7 0 – – – – – 
TABLE IV 
CAH and CPH. Stigmata of drug abuse in drug abusers. 
Patient 
Group 
No. of 
Patients 
Needle 
Marks 
Skin 
Abscess 
CAH 12 9 – 
CPH 12 12 3 
 Two of the drug abusing patients with chronic active hepatitis developed jaundice 
during the course of follow up. None of the non drug abusing patients with 
TABLE V 
SGPT levels in CAH. 
Onset 12 months 
SGPT U/I Drug 
abusers 
Non 
abusers 
Drug 
abusers 
Non 
abusers 
45 2 – 7 3 
100 1 1 2 6 
300 2 3 2 1 
1000 5 4 1 – 
2000 2 2 – – 
chronic active hepatitis did so. In the group of patients with chronic persistent hepatitis all of 
the drug abusing patients remained clinically well during the course of follow up, 2 of the non 
drug abusing patients developed jaundice. 
 Three of the drug abusing patients with chronic active hepatitis claimed to have ceased 
abusing drugs, one of the drug abusing patients with chronic persistent hepatitis claimed to 
have ceased abusing. 
TABLE VI 
SGPT levels in CPH. 
Onset 12 months 
SGPT U/I Drug 
abusers 
Non 
abusers 
Drug 
abusers 
Non 
abusers 
45 2 1 2 6 
100 2 1 6 1 
300 1 2 4 – 
500 3 – – – 
1000 3 1 – – 
2000 1 2 – – 
 
 
 TABLE VII 
Abnormal immunoglobulins, elevated total serum proteins, antinuclear factor (ANF), smooth 
muscle antibody (SMA), antimitochondrial antibody (AMA) in each group of patients. 
Patient 
group 
Number of 
patients 
Abnormal 
Immunoglo-
bulins 
Total serum 
proteins 
80g/l 
ANF SMA AMA 
Drug abusers 
with CAH 
12 3 (2 returned 
to normal) 
– – 1 – 
Non abusers 
With CAH 
10 5 3 3 2 – 
Drug abusers 
With CPH 
12 3 – – – – 
Non abusers 
With CPH 
7 – – 1 2 – 
Histology (Tables IX-XII) 
 Four of the drug abusing patients had chronic active hepatitis with cirrhosis on their 
initial biopsy; on follow up biopsy one showed histological deterioration with hepatocellular 
necrosis, marked swelling of the portal tracts and a heavy mononuclear cell infiltrate; whilst 2 
were basically unchanged although one showed less cellular activity, and one had no repeat 
biopsy. Three patients with chronic active hepatitis on initial biopsy showed less cellular 
activity and no progression in the degree of fibrosis on repeat biopsy; one of these had a third 
biopsy and another a fourth biopsy 
TABLE VIII 
HBsAg status in each group of patients. 
Patient 
group 
Number of 
patients 
HBsAg 
positive 
HBsAg 
positive 
in past 
HBsAg and 
antibody 
negative 
HBsAg 
negative 
Drug abusers 
with CAM 
12 5 4 3 — 
Non abusers 
with CAH 
10 4 — — 6 
Drug abusers 
with CPH 
12 3 2 6 1 
Non abusers 
with CPH 
7 1 — — 6 
 
 
 
 
 
 
 
 
 
 TABLE IX 
CAH. Histology in drug abusers. 
(Time in months from initial biopsy in brackets). 
1st Biopsy 2nd Biopsy 3rd Biopsy 4th Biopsy 
Cirrhosis Cirrhosis (11) Cirrhosis with 
less activity (20) 
 
Cirrhosis Cirrhosis (8)   
Cirrhosis Cirrhosis (6) Cirrhosis with 
more activity (23) 
 
Cirrhosis –   
CAH CAH with less CPH (20) 
activity (12) 
CPH (32) 
CAH Minor 
Changes (32) 
  
CAH CAH with less 
activity (10) 
CPH (18)  
CAH CAH (8)   
CAH CAH with more 
Activity and  
Fibrosis (6) 
  
CAH CAH with less 
activity more 
fibrosis (6) 
  
CAH CAH with less 
activity (30) 
  
CAH –   
showing chronic persistent hepatitis. One patient with chronic active hepatitis showed less 
cellular activity but more fibrosis on repeat biopsy. One patient had minor changes only on 
repeat biopsy. 
 Seven of 10 non drug abusing patients with chronic active hepatitis had cirrhosis on 
initial biopsy; one of these progressively improved showing minor changes only on a fifth 
biopsy. Two patients showed less cellular activity on repeat biopsy. Three patients without 
cirrhosis on initial biopsy progressed to it. 
 Ten of 12 drug abusers with chronic persistent hepatitis were essentially unchanged on 
repeat biopsy. One patient had chronic active hepatitis on a third biopsy and chronic active 
hepatitis with cirrhosis on a fourth biopsy. One patient had minor changes on a second biopsy 
and chronic persistent hepatitis on a third. 
 In the non drug abusing patients with chronic persistent hepatitis no patient progressed 
to chronic active hepatitis with or without cirrhosis, although one patient showed increased 
fibrosis on a-second biopsy. Four patients were unchanged on a second biopsy; one of these 
had minor changes on a third biopsy and normal histology on a fourth biopsy. One patient 
who had chronic persistent hepatitis on initial biopsy had minor changes on a second biopsy, 
 
 
 
 
 
 
 TABLE X 
CAH. Histology in non drug abusing patients. 
(Time in months from initial biopsy in brackets). 
1st Biopsy 2nd Biopsy 3rd Biopsy 4th Biopsy 5th Biopsy 6th Biopsy 
CAH with 
early 
cirrhosis 
Established 
cirrhosis more 
activity (22) 
Cirrhosis (32) Cirrhosis (45)   
CAH with 
early 
cirrhosis 
Increased 
activity 
increased 
fibrosis (5) 
Cirrhosis with 
less activity 
(20) 
Cirrhosis (32) Cirrhosis (44)  
CAH with 
cirrhosis 
Cirrhosis with 
less cellular 
activity (6) 
Fibrosis less 
obvious (40) 
Minor changes 
(60) 
  
CAH with 
cirrhosis 
Cirrhosis with 
continuing 
activity (10) 
Cirrhosis (24)    
CAH CAH with early 
cirrhosis (24) 
Established 
cirrhosis (33) 
Cirrhosis– 
Progressive 
severity (42) 
Cirrhosis (54) Cirrhosis (70) 
CAH CAH with early 
cirrhosis (6) 
Established 
cirrhosis (15) 
Cirrhosis (29)   
CAH CAH with 
cirrhosis (12) 
Cirrhosis (60)    
CAH with 
cirrhosis 
CAH with 
cirrhosis (12) 
Progressive 
cirrhosis (24) 
   
CAH with 
cirrhosis 
Cirrhosis with 
less activity 
(12) 
    
CAH with 
cirrhosis 
Cirrhosis with 
less cellular 
activity (14) 
    
TABLE XI 
CPH. Histology in drug abusers. 
(Time in months from initial biopsy in brackets). 
1st Biopsy 2nd Biopsy 3rd Biopsy 
CPH CPH (22)  
CPH CPH (6)  
CPH CPH (7)  
CPH CPH (6)  
CPH CPH (15)  
CPH CPH (22)  
CPH CPH (6)  
CPH CPH (9)  
CPH CPH (10)  
CPH CPH (48)  
CPH Minor changes (3)  CPH (17) 
CPH CAH (6)  CAH with 
 cirrhosis (13) 
chronic persistent hepatitis on a third and minor changes on a fourth biopsy. 
 In addition to the other changes described fatty infiltration was found in one drug 
abusing patient with chronic active hepatitis, one drug abuser with chronic persistent hepatitis, 
one non drug abusing patient with chronic active hepatitis and 2 non drug abusing patients 
with chronic persistent hepatitis. 
Discussion 
 Several interesting findings emerged from this study. In both histological groups the 
mean age of the drug abusers was younger and the mean duration of follow up shorter than in 
the non drug abusers. Of those patients with chronic active hepatitis there were 5 men and 5 
women in the non drug abusing group compared with 11 men and one woman in the drug 
abusers. There was more clinical evidence of liver disease in the non drug abusing patients 
with chronic active hepatitis in whom 6 of 10 had stigmata of liver disease compared 
TABLE XII 
CPH. Histology in non drug abusers. 
(Time in months from initial biopsy in brackets). 
1st Biopsy 2nd Biopsy 3rd Biopsy 4th Biopsy 
CPH CPH with more 
fibrosis (36) 
  
CPH CPH (12)   
CPH CPH (27)   
CPH CPH (33)   
CPH CPH (3) Minor changes (23)  
CPH with acute 
hepatitis 
Minor changes (7) CPH (24) Minor changes (36) 
CPH Minor changes (5) Minor changes (20) Normal (42) 
with only 3 of 12 drug abusers. More patients in the non drug abusing group had abnormal 
serum proteins and immunoglobulins. Nine of 12 drug abusers had past or present evidence of 
hepatitis B virus; infection compared with 4 of 10 non drug abusers. No drug abusing patient 
without cirrhosis on initial biopsy developed it although one patient showed more fibrosis and 
more cellular activity on repeat biopsy. Two patients showed chronic persistent hepatitis on 
follow up biopsy and one patient showed minor changes only. 
 The non drug abusing group of patients with chronic active hepatitis had histologically 
more advanced disease than the drug abusers. Seven of 10 patients had cirrhosis on initial 
biopsy and the remaining 3 developed it. One patient showed apparent histological recovery. 
The higher frequency of abnormality of immunoglobulins, serum proteins, antinuclear factor 
and smooth muscle antibody together with the greater number of females in this group would 
suggest that those patients who were HBsAg negative had chronic active hepatitis of the 
lupoid variety. This tends to have a poor prognosis with cirrhosis developing rapidly 
(Sherlock, 1974) which would correlate with the findings in this study. 
 Sherlock (1974) believes that HBsAg associated chromic active hepatitis had a better 
prognosis than the lupoid type. Although this is not a universally held belief (De Groote, 
Fevery and Lepourtre, 1978) our study would appear to support it. Spontaneous remissions of 
chronic active hepatitis have been reported (Soloway et at, 1972; Summershill, 1974); the 
presence of cirrhosis does not preclude remission (Soloway et al, 1972). This may account for 
the 2 histological remissions which occurred, one in the drug abusing and the other in the non 
abusing group. 
 In this study the histological abnormality of chronic persistent hepatitis tended to 
persist (10 of 12) or progress (one of 12) in the drug abusing patients while in the non drug 
abusing patients spontaneous remission tended to occur more frequently with minor changes 
only remaining in the liver. The benign nature of chronic persistent hepatitis previously 
documented (Becker et al, 1970) is thus confirmed. Recently progression of chronic persistent 
hepatitis to chronic active hepatitis has been described (Chadwick et al, 1970). It is felt by 
some people that between the histological diagnosis of chronic active and chronic persistent 
hepatitis there is a continuum of histologic abnormality (Scheurer, 1977); and progression of 
chronic persistent hepatitis to cirrhosis has been documented (Van Waes et al, 1974; 
Dietrichson, 1975). Apparent histological remission of chronic persistent hepatitis as occurred 
in our study has also been described; in Dietrichson’s study (1975) 16 patients with chronic 
persistent hepatitis had one or more repeat biopsies; 3 patients had non specific portal tract 
changes and one patient had no histological abnormality on repeat biopsy. Sherlock and her 
associates (1979) describe apparent remission in one patient of 16 with chronic persistent 
hepatitis. 
 We are aware of the limitations of conclusions based in individual biopsies but 
repeated biopsies on individuals and 2 or more biopsies in a number of patients allow firmer 
deductions to be made. Chronic active hepatitis tends to be less severe histologically and 
progress to cirrhosis less frequently in drug abusers than in non abusers; while the histological 
changes of chronic persistent hepatitis tend to persist or progress to chronic active hepatitis In 
drug abusers and regress in non drug abusers. Such persistence or progression in drug abusers 
may be related to continued drug abuse as the majority of our drug abusing patients continued 
to abuse drugs. 
References 
Becker, M. D., Baptista, A., Scheurer, P. J., Sherlock, S. 1970. Lancet i, 53-57. 
Chadwick, R. G., Galizzi, J., Heathcote, T., Lyssiotis, T., Cohen, B. J., Bcheurer, P. J. and 
Sherlock, S. 1970. Gut 20, 372-377. 
De Groote, J., Pevery, J. and Lepourtre, L. 1978. Gut 19, 510-153. 
Dietrichson, O., Scard, J. 1975. Gastroenterology 10, 249-255. 
McCance, R. A., Widdowson, E. M. 1967. Spec. Rep. Scr. Med. Res. Count. Lon. No. 297. 
Review by an International Group. 1977. Lancet ii, 914-919. 
Scheurer, P. J. 1977. Histopathology i, 5-19. 
Sherlock, Sheila. 1974. Gut 15, 581-597. 
Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Sitnick, G., 
Elvehack, L. R. and Schoenfield, L. J. 1972. Gastroenterology 63, 5, 820-833. 
Summerskill, W. H. J. 1974. Gastroenterology 66, 450-464. 
Van Waes, L., Segers, J., Van Edmond, J., Van Nimmen, L., Barhier, F., Wieme, R. and 
Demeulencre, L. 1974. Brit. Med. J. iii, 444-446. 
